Henry Schein Shares Outstanding 2011-2025 | HSIC
Henry Schein shares outstanding history from 2011 to 2025. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
- Henry Schein shares outstanding for the quarter ending June 30, 2025 were 0.123B, a 4.67% decline year-over-year.
- Henry Schein 2024 shares outstanding were 0.128B, a 3.01% decline from 2023.
- Henry Schein 2023 shares outstanding were 0.132B, a 4.36% decline from 2022.
- Henry Schein 2022 shares outstanding were 0.138B, a 2.83% decline from 2021.
|
Henry Schein Annual Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2024 | 128 |
| 2023 | 132 |
| 2022 | 138 |
| 2021 | 142 |
| 2020 | 143 |
| 2019 | 149 |
| 2018 | 154 |
| 2017 | 158 |
| 2016 | 164 |
| 2015 | 168 |
| 2014 | 171 |
| 2013 | 175 |
| 2012 | 180 |
| 2011 | 185 |
| 2010 | 187 |
|
Henry Schein Quarterly Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2025-06-30 | 123 |
| 2025-03-31 | 125 |
| 2024-12-31 | 128 |
| 2024-09-30 | 127 |
| 2024-06-30 | 129 |
| 2024-03-31 | 130 |
| 2023-12-31 | 132 |
| 2023-09-30 | 131 |
| 2023-06-30 | 132 |
| 2023-03-31 | 133 |
| 2022-12-31 | 138 |
| 2022-09-30 | 137 |
| 2022-06-30 | 139 |
| 2022-03-31 | 139 |
| 2021-12-31 | 142 |
| 2021-09-30 | 141 |
| 2021-06-30 | 142 |
| 2021-03-31 | 143 |
| 2020-12-31 | 143 |
| 2020-09-30 | 143 |
| 2020-06-30 | 142 |
| 2020-03-31 | 143 |
| 2019-12-31 | 149 |
| 2019-09-30 | 149 |
| 2019-06-30 | 149 |
| 2019-03-31 | 151 |
| 2018-12-31 | 154 |
| 2018-09-30 | 154 |
| 2018-06-30 | 154 |
| 2018-03-31 | 154 |
| 2017-12-31 | 158 |
| 2017-09-30 | 158 |
| 2017-06-30 | 159 |
| 2017-03-31 | 160 |
| 2016-12-31 | 164 |
| 2016-09-30 | 164 |
| 2016-06-30 | 165 |
| 2016-03-31 | 165 |
| 2015-12-31 | 168 |
| 2015-09-30 | 168 |
| 2015-06-30 | 168 |
| 2015-03-31 | 169 |
| 2014-12-31 | 171 |
| 2014-09-30 | 171 |
| 2014-06-30 | 172 |
| 2014-03-31 | 173 |
| 2013-12-31 | 175 |
| 2013-09-30 | 175 |
| 2013-06-30 | 176 |
| 2013-03-31 | 178 |
| 2012-12-31 | 180 |
| 2012-09-30 | 179 |
| 2012-06-30 | 181 |
| 2012-03-31 | 181 |
| 2011-12-31 | 185 |
| 2011-09-30 | 186 |
| 2011-06-30 | 187 |
| 2011-03-31 | 186 |
| 2010-12-31 | 187 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $8.464B | $12.673B |
| Henry Schein Inc. is a leading distributor of health care products and services across the globe. The company serves office-based dental, medical and animal health practitioners, dental laboratories, government as well as institutional health care clinics and other alternate-care sites. Henry Schein's 3 businesses - Dental, Medical and Technology and Value-Added Services serve millions of customers worldwide. Henry Schein has completed the spinoff of its global Animal Health business. The global dental group serves office-based dental practitioners, dental laboratories, schools and other institutions. The global medical group serves office-based medical practitioners, ambulatory surgery centers, other alternate-care settings and other institutions. The global technology and value-added services group provides software, technology and other value-added services to health care practitioners. The technology group offerings include practice management software systems for dental and medical practitioners. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| McKesson (MCK) | United States | $105.158B | 23.49 |
| Becton Dickinson (BDX) | United States | $50.974B | 12.33 |
| Cardinal Health (CAH) | United States | $48.391B | 22.86 |
| West Pharmaceutical Services (WST) | United States | $19.500B | 38.34 |
| Straumann Holding AG (SAUHY) | Switzerland | $19.310B | 0.00 |
| Cooper (COO) | United States | $13.937B | 17.44 |
| Align Technology (ALGN) | United States | $9.675B | 18.27 |
| Merit Medical Systems (MMSI) | United States | $5.191B | 25.52 |
| DENTSPLY SIRONA (XRAY) | United States | $2.230B | 7.08 |
| CONMED (CNMD) | United States | $1.361B | 9.73 |
| STAAR Surgical (STAA) | United States | $1.321B | 0.00 |
| Pro-Dex (PDEX) | United States | $0.101B | 12.04 |
| Lifevantage (LFVN) | United States | $0.094B | 8.92 |